Recombinant proteins are essential tools in modern life science research. From cell culture and immunology to drug discovery and advanced therapies, they enable breakthroughs across disciplines. But not all proteins are created equal.
TargetMol’s white paper reveals how a catalog of over 13,000 recombinant proteins can elevate your experiments to the next level.
Recombinant proteins produced via DNA/RNA technology offer significant advantages over natural sources:
High yield and reproducibility
Controlled quality and purity
Broad range of species, tags, and modifications
This makes them ideal for applications such as:
Cell-based assays and culture
Protein structure and function studies
Immunology and virology research
Drug discovery and development
Cell and gene therapy
Comprehensive portfolio: Cytokines, growth factors, CAR-T targets, checkpoint proteins, enzymes, viral proteins, and more
Flexible expression systems: E. coli, HEK293, insect cells, yeast, cell-free systems, and virus-like particles
Validated quality: Each product undergoes SDS-PAGE, HPLC, and biological activity testing. Most products have endotoxin levels below 1 EU/μg, some even under 0.01 EU/μg
Product highlight: Human TNF-alpha (TMPY-00936) demonstrates exceptional activity with an ED50 as low as 3–30 pg/mL in cytotoxicity assays
Cytokines
EGF – Human, E. coli, tag-free
M-CSF – Mouse, HEK293, tag-free
TNF-alpha – Human, E. coli, tag-free
CAR-T Therapy Targets
HER2 – Human, HEK293
EGFR – Human, HEK293, His tag
BCMA – Human, HEK293, His tag
Immune Checkpoint Proteins
PD-1 – Human, HEK293, His tag
CTLA-4 – Human, HEK293, tag-free
TIM-3 – Human, HEK293, His tag
Viral Antigens
Hemagglutinin – Influenza A H3N2
gp120 – HIV-1
Fusion Glycoprotein – RSV